Stockreport

Aviragen Therapeutics Reports First Quarter of Fiscal Year 2018 Financial Results

Atea Pharmaceuticals, Inc. - common stock  (AVIR) 
PDF ATLANTA, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ:AVIR) today announced its financial results for the three months ended September 30, 201 [Read more]